LifeMD to Report Third Quarter 2026 Financial Results on November 9
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
HC Wainwright & Co. Reiterates Buy on LifeMD, Maintains $9 Price Target
LifeMD: Still Undervalued Despite Earnings Miss
LifeMD (LFMD) Stock Sees Fair Value Cut After Analysts Lower Targets On Weaker Guidance
LifeMD: What The Bulls Got Wrong
LifeMD (LFMD) Q2 2026 Earnings Call Transcript
LifeMD, Inc. 2026 Q2 - Results - Earnings Call Presentation
HC Wainwright & Co. Maintains Buy on LifeMD, Lowers Price Target to $9
LifeMD, Inc. Q2 2026 Earnings Call Summary
B. Riley Securities Maintains Buy on LifeMD, Lowers Price Target to $8
LifeMD, Inc. (LFMD) Q2 2026 Earnings Call Transcript
BTIG Maintains Buy on LifeMD, Lowers Price Target to $9
LifeMD Q2 Earnings Call Highlights
LifeMD (NASDAQ:LFMD) Shares Slide After Q2 Revenue and EPS Miss
LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates
UPDATE - LifeMD Reports Second Quarter 2026 Results
LifeMD Reports Second Quarter 2026 Results
LifeMD Lowers FY2026 Sales Guidance from $220.000M-$230.000M to $205.500M-$212.500M vs $222.046M Est
LifeMD Sees Q3 Sales $48.000M-$51.000M vs $58.547M Est
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.